Cargando…
Impact of glycemic control in diabetes mellitus on management of COVID-19 infection
BACKGROUND: Diabetes mellitus may be associated with increased severity and enhanced mortality in COVID-19 infections. The present study was undertaken to evaluate the clinical presentation, laboratory parameters, radiological imaging, management, and outcome of COVID-19 infection in patients of dia...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466921/ https://www.ncbi.nlm.nih.gov/pubmed/32905072 http://dx.doi.org/10.1007/s13410-020-00868-7 |
_version_ | 1783577916853977088 |
---|---|
author | Bhandari, Sudhir Rankawat, Govind Singh, Ajeet Gupta, Vishal Kakkar, Shivankan |
author_facet | Bhandari, Sudhir Rankawat, Govind Singh, Ajeet Gupta, Vishal Kakkar, Shivankan |
author_sort | Bhandari, Sudhir |
collection | PubMed |
description | BACKGROUND: Diabetes mellitus may be associated with increased severity and enhanced mortality in COVID-19 infections. The present study was undertaken to evaluate the clinical presentation, laboratory parameters, radiological imaging, management, and outcome of COVID-19 infection in patients of diabetes mellitus and its association with glycemic control. METHODS: The present study was designed to evaluate the difference between uncontrolled and controlled diabetes for COVID-19 manifestations by enrolling 80 admitted COVID-19 patients. Patients were categorized into two groups, where group 1 had patients with uncontrolled diabetes as indicated by HbA1c > 8 g% and group 2 had patients with controlled diabetes as indicated by HbA1c < 8 g%. Information concerning medical history, clinical manifestations, laboratory findings, radiological imaging, management, and outcome was extracted from medical records for evaluation, interpretation, and association among both the groups. RESULTS: COVID-19 patients with uncontrolled diabetes exhibited a severe symptomatic presentation, excessive uncontrolled inflammatory responses, and hypercoagulable state. Total leukocyte count, neutrophil-lymphocyte ratio, serum levels of IL-6, FDP, and D-dimer were significantly raised (p < 0.05) in case of uncontrolled diabetes as compared with controlled diabetes. Radiological findings detected by chest radiograph and computed tomography chest suggested severe lung involvement in uncontrolled diabetes. COVID-19 patients with uncontrolled diabetes required intensive treatment as compared with controlled diabetes group in terms of insulin therapy (p = 0.0226) and non-invasive ventilation (p = 0.0292). Patients with uncontrolled diabetes had higher mortality (p = 0.0375) and required prolonged hospitalization (p = 0.0479) as compared with controlled diabetes group. CONCLUSION: From the current study, it can be concluded that uncontrolled diabetic condition might be a risk factor for severity and morbidity of COVID-19 patients. Uncontrolled diabetes mellitus might be responsible for an overall higher susceptibility for COVID-19 infection and severity in terms of symptomatic presentation, inflammatory storm, rapid pulmonary invasion, requirement of more intensive treatment, and a poor outcome. |
format | Online Article Text |
id | pubmed-7466921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-74669212020-09-02 Impact of glycemic control in diabetes mellitus on management of COVID-19 infection Bhandari, Sudhir Rankawat, Govind Singh, Ajeet Gupta, Vishal Kakkar, Shivankan Int J Diabetes Dev Ctries Original Article BACKGROUND: Diabetes mellitus may be associated with increased severity and enhanced mortality in COVID-19 infections. The present study was undertaken to evaluate the clinical presentation, laboratory parameters, radiological imaging, management, and outcome of COVID-19 infection in patients of diabetes mellitus and its association with glycemic control. METHODS: The present study was designed to evaluate the difference between uncontrolled and controlled diabetes for COVID-19 manifestations by enrolling 80 admitted COVID-19 patients. Patients were categorized into two groups, where group 1 had patients with uncontrolled diabetes as indicated by HbA1c > 8 g% and group 2 had patients with controlled diabetes as indicated by HbA1c < 8 g%. Information concerning medical history, clinical manifestations, laboratory findings, radiological imaging, management, and outcome was extracted from medical records for evaluation, interpretation, and association among both the groups. RESULTS: COVID-19 patients with uncontrolled diabetes exhibited a severe symptomatic presentation, excessive uncontrolled inflammatory responses, and hypercoagulable state. Total leukocyte count, neutrophil-lymphocyte ratio, serum levels of IL-6, FDP, and D-dimer were significantly raised (p < 0.05) in case of uncontrolled diabetes as compared with controlled diabetes. Radiological findings detected by chest radiograph and computed tomography chest suggested severe lung involvement in uncontrolled diabetes. COVID-19 patients with uncontrolled diabetes required intensive treatment as compared with controlled diabetes group in terms of insulin therapy (p = 0.0226) and non-invasive ventilation (p = 0.0292). Patients with uncontrolled diabetes had higher mortality (p = 0.0375) and required prolonged hospitalization (p = 0.0479) as compared with controlled diabetes group. CONCLUSION: From the current study, it can be concluded that uncontrolled diabetic condition might be a risk factor for severity and morbidity of COVID-19 patients. Uncontrolled diabetes mellitus might be responsible for an overall higher susceptibility for COVID-19 infection and severity in terms of symptomatic presentation, inflammatory storm, rapid pulmonary invasion, requirement of more intensive treatment, and a poor outcome. Springer India 2020-09-02 2020-09 /pmc/articles/PMC7466921/ /pubmed/32905072 http://dx.doi.org/10.1007/s13410-020-00868-7 Text en © Research Society for Study of Diabetes in India 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Bhandari, Sudhir Rankawat, Govind Singh, Ajeet Gupta, Vishal Kakkar, Shivankan Impact of glycemic control in diabetes mellitus on management of COVID-19 infection |
title | Impact of glycemic control in diabetes mellitus on management of COVID-19 infection |
title_full | Impact of glycemic control in diabetes mellitus on management of COVID-19 infection |
title_fullStr | Impact of glycemic control in diabetes mellitus on management of COVID-19 infection |
title_full_unstemmed | Impact of glycemic control in diabetes mellitus on management of COVID-19 infection |
title_short | Impact of glycemic control in diabetes mellitus on management of COVID-19 infection |
title_sort | impact of glycemic control in diabetes mellitus on management of covid-19 infection |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466921/ https://www.ncbi.nlm.nih.gov/pubmed/32905072 http://dx.doi.org/10.1007/s13410-020-00868-7 |
work_keys_str_mv | AT bhandarisudhir impactofglycemiccontrolindiabetesmellitusonmanagementofcovid19infection AT rankawatgovind impactofglycemiccontrolindiabetesmellitusonmanagementofcovid19infection AT singhajeet impactofglycemiccontrolindiabetesmellitusonmanagementofcovid19infection AT guptavishal impactofglycemiccontrolindiabetesmellitusonmanagementofcovid19infection AT kakkarshivankan impactofglycemiccontrolindiabetesmellitusonmanagementofcovid19infection |